Comparison of Two Creatinine-Based Equations for Predicting Decline in Renal Function in Type 2 Diabetic Patients with Nephropathy in a Korean Population

Table 1

Demographic and baseline characteristics of the participants (𝑛=707).

Variables	All
Male/female	416/291
Age (years)	61.9±12.2
Duration of diabetes (years)	12.7±8.9
Duration of follow-up (months)	35.9±49.6
HbA1c (%)	8.2±4.3
Cr (mg/dL)	1.59±1.24
eGFR CKD-EPI(mL/min/1.73 m^2)	59.08±30.27
Stages, 𝑛 (%)
Stage 1: ≥90	120 (17.0)
Stage 2: 60–89	222 (31.4)
Stage 3a: 45–59	102 (14.4)
Stage 3b: 30–44	113 (16.0)
Stage 4: 15–29	104 (14.7)
Stage 5: <15	46 (6.5)
eGFR MDRD (mL/min/1.73 m^2)	58.01±31.77
Stages, 𝑛 (%)
Stage 1: ≥90	96 (13.6)
Stage 2: 60–89	229 (32.4)
Stage 3a: 45–59	107 (15.1)
Stage 3b: 30–44	122 (17.3)
Stage 4: 15–29	111 (15.7)
Stage 5: <15	42 (5.9)
24 hr urinary albumin excretion (mg/day)	1094.58±1867.38
Total cholesterol (mg/dL)	174.1±53.9
Triglycerides (mg/dL)	169.6±140.4
HDL cholesterol (mg/dL)	43.5±15.1
LDL cholesterol (mg/dL)	99.3±42.2
Oral hypoglycemic agents (%)	495 (69.9)
Insulin therapy (%)	184 (26.0)
Antihypertensive agents (%)	483 (68.2)
Lipid-lowering agents (%)	268 (37.9)

Data are shown as means ± SD or number of the case (%).